Nasal Intermittent Positive Pressure Ventilation in Premature Infants (NIPPV) (NIPPV)
Efficacy and Safety of NIPPV to Increase Survival Without Bronchopulmonary Dysplasia in Extremely Low Birth Weight Infants
The machines and oxygen used to help very premature babies breathe can have side-effects, such as bronchopulmonary dysplasia (BPD). Infants with BPD get more complications (a higher death rate, a longer time in intensive care and on assisted ventilation, more hospital readmissions in the first year of life, and more learning problems) than infants who do not develop BPD. Doctors try to remove the tube in the wind-pipe that links the baby to the breathing machine as soon as possible. However, small babies get tired, and still require help to breathe. One of the standard and common techniques to help them breathe without a tube in the wind-pipe is to use simple pressure support, nasal continuous positive airway pressure or nCPAP. This supports breathing a little, but it is often not enough to prevent the need to go back on the breathing machine.
Nasal intermittent positive pressure ventilation (NIPPV) is similar to nCPAP, but also gives some breaths, or extra support, to babies through a small tube in the nose. NIPPV is safe and effective, and already in use as an alternate "standard" therapy.
The main research question: After being weaned from the breathing machine, is NIPPV better than nCPAP in preventing BPD in premature babies weighing 999 grams or less at birth?
Studie Overzicht
Toestand
Interventie / Behandeling
Gedetailleerde beschrijving
The immature lung of extremely low birth weight (ELBW, < 1000 g) infants is easily damaged by the placement of an endotracheal tube to deliver mechanical ventilation and oxygen. This and the total time of mechanical ventilation contributes to bronchopulmonary dysplasia (BPD). Infants with BPD have an increased risk of later death or neuro-impairment. With the increasing survival of ELBW infants in the NICU, there has been a proportionate increase in the number of infants surviving with BPD.
Following invasive ventilation via an endotracheal tube (ETT), extubation to nasal Continuous Positive Airway Pressure (nCPAP)ventilation is the standard approach. Currently, 40% of infants who are extubated and given nCPAP support fail, and require re-intubation. Previous work suggests that a less invasive respiratory support such as Nasal Intermittent Positive Pressure Ventilation (NIPPV), without an endotracheal tube is less injurious to the lung. NIPPV may thereby reduce the duration of invasive ventilator support, and aid successful early extubation. We hypothesize that the use of NIPPV leads to a higher rate of survival without BPD than standard therapy with nCPAP.
This randomized clinical trial is appropriately powered to compare NIPPV with nCPAP to detect effects on clinically relevant long-term outcomes, such as death and BPD at 36 weeks. This is a multi-national, randomized, open clinical trial of two different standard methods of providing non-invasive respiratory support to 1000 extremely preterm infants weighing less than 1000 grams at birth.
Studietype
Inschrijving (Werkelijk)
Fase
- Fase 3
Contacten en locaties
Studie Locaties
-
-
-
Rocourt, België, B-4000
- CHC St. Vincent
-
-
-
-
Manitoba
-
Winnipeg, Manitoba, Canada
- Winnipeg Health Sciences Centre
-
Winnipeg, Manitoba, Canada, R3E 0L8
- St. Boniface General Hospital/University of Manitoba
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada
- IWK Health Centre
-
-
Ontario
-
Hamilton, Ontario, Canada, L8S 4J9
- McMaster University
-
Ottawa, Ontario, Canada, K1H 8L1
- Children's Hospital of Eastern Ontario
-
Ottawa, Ontario, Canada, K1H 8L6
- The Ottawa Hospital General Campus
-
Toronto, Ontario, Canada
- Hospital for Sick Children
-
-
Saskatchewan
-
Saskatoon, Saskatchewan, Canada
- Royal University Hospital
-
-
-
-
-
Dublin, Ierland
- National Maternity Hospital
-
Dublin, Ierland
- Coombe Women's Hospital
-
-
Cork
-
Wilton, Cork, Ierland
- Cork University Maternity Hospital
-
-
-
-
-
Doha, Katar
- Hamad Medical Corporation
-
-
-
-
-
Groningen, Nederland, 9700 RB
- University Medical Center Groningen/Beatrix Children's Hosp
-
Zwolle, Nederland, 8000 GK
- Princess Amalia Dept of Pediatrics, Isala Clinics
-
-
-
-
-
Feldkirch, Oostenrijk, 6800
- LKH Feldkirch
-
-
-
-
-
Singapore, Singapore, 229899
- KK Women's and Children's Hospital
-
-
-
-
-
Leicester, Verenigd Koninkrijk, LE1 6TP
- University of Leicester
-
London, Verenigd Koninkrijk, W2 1NY
- St. Mary's Hospital
-
-
Northern Ireland
-
Belfast, Northern Ireland, Verenigd Koninkrijk, BT12 6BB
- Royal Maternity Hospital
-
-
-
-
District of Columbia
-
Washington, District of Columbia, Verenigde Staten, 20037
- The George Washington University Hospital
-
Washington, District of Columbia, Verenigde Staten, 20007
- Georgetown University Children's Medical Center
-
-
Massachusetts
-
Boston, Massachusetts, Verenigde Staten, 02215
- Beth Israel Deaconess Medical Center (Bidmc)
-
Boston, Massachusetts, Verenigde Staten, 02111
- Tufts University Medical Center
-
-
New Jersey
-
Voorhees, New Jersey, Verenigde Staten, 08043
- Virtua West Jersey Hospital
-
-
New York
-
Brooklyn, New York, Verenigde Staten, 11203
- Kings County Hospital
-
Brooklyn, New York, Verenigde Staten, 11023
- SUNY Downstate Medical Center
-
Brooklyn, New York, Verenigde Staten, 11355
- New York Hospital Queens
-
Jamaica, New York, Verenigde Staten, 11432
- Queens Hospital Center
-
New York, New York, Verenigde Staten, 11212
- Brookdale University Hospital & Medical Center
-
Stony Brook, New York, Verenigde Staten, 11794-8111
- Stony Brook University Medical Center
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Verenigde Staten, 19104
- Children's Hospital of Philadelphia
-
Philadelphia, Pennsylvania, Verenigde Staten, 19035
- Pennsylvania Hospital/U. of Pennsylvania
-
-
Utah
-
Salt Lake City, Utah, Verenigde Staten, 84158-1289
- University of Utah
-
-
-
-
-
Stockholm, Zweden, S-171 76
- Karolinska University Hospital/Astrid Lingrenn's Children's Hospital
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Birth weight <1000 gm
- Gestational age <30 completed weeks
Intention to manage the infant with non-invasive respiratory support (i.e. no endotracheal tube), where either:
- the infant is within the first 7 days of life and has never been intubated or has received less than 24 hours of total cumulative intubated respiratory support;
- the infant is within the first 28 days of life, has been managed with intubated respiratory support for 24 hours or more and is a candidate for extubation followed by non-invasive respiratory support.
Exclusion Criteria:
- Considered non-viable by clinician (decision not to administer effective therapies)
- Life-threatening congenital abnormalities including congenital heart disease (excluding patent ductus arteriosis)
- Infants known to require surgical treatment
- Abnormalities of the upper and lower airways
- Neuromuscular disorders
- Infants who are >28 days old and continue to require mechanical ventilation with an endotracheal tube
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Preventie
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Actieve vergelijker: A
Non-invasive respiratory support via nasal intermittent positive pressure ventilation
|
Deliver non-invasive respiratory support via ventilator with NIPPV device
|
|
Actieve vergelijker: B
Non-invasive respiratory support via nasal Continuous Positive Airway Pressure
|
Deliver non-invasive respiratory support via ventilator with nCPAP device
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
|---|---|
|
Composite of survival to 36 weeks gestational age, free of moderate-severe bronchopulmonary dysplasia
Tijdsspanne: 36 weeks gestational age
|
36 weeks gestational age
|
Secundaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
|---|---|
|
Mortaliteit door alle oorzaken bij een zwangerschapsduur van 36 weken
Tijdsspanne: 36 weken zwangerschapsduur
|
36 weken zwangerschapsduur
|
|
retinopathie van vroeggeboorte
Tijdsspanne: ontslag naar huis
|
ontslag naar huis
|
|
All cause mortality before first discharge home
Tijdsspanne: first discharge home
|
first discharge home
|
|
ultrasonographic evidence of brain injury
Tijdsspanne: 36 weeks gestional age
|
36 weeks gestional age
|
|
necrotizing enterocolitis
Tijdsspanne: 36 weeks gestational age
|
36 weeks gestational age
|
|
growth
Tijdsspanne: discharge home
|
discharge home
|
|
time to establish full feeds
Tijdsspanne: discharge home
|
discharge home
|
|
nosocomial infections
Tijdsspanne: discharge home
|
discharge home
|
|
need for re-intubation
Tijdsspanne: 36 weeks gestational age
|
36 weeks gestational age
|
|
time on supplemental oxygen
Tijdsspanne: discharge home
|
discharge home
|
|
duration of positive pressure respiratory support
Tijdsspanne: discharge home
|
discharge home
|
|
comparison of synchronized and non-synchronized NIPPV
Tijdsspanne: discharge home
|
discharge home
|
|
bronchopulmonary dysplasia
Tijdsspanne: 36 weeks gestational age
|
36 weeks gestational age
|
|
air leak syndromes
Tijdsspanne: 36 weeks gestational age
|
36 weeks gestational age
|
|
nasal trauma
Tijdsspanne: discharge home
|
discharge home
|
Medewerkers en onderzoekers
Sponsor
Medewerkers
Onderzoekers
- Studie stoel: Haresh Kirpalani, MD, MSc, Hamilton Health Sciences Corporation
- Studie directeur: Brigitte Lemyre, MD, Children's Hospital of Eastern Ontario
- Studie directeur: Aaron Chiu, MD, St. Boniface Hospital
- Studie directeur: David Millar, MD, Royal Maternity Hospital, Belfast
- Studie directeur: Robin S Roberts, MTech, Hamilton Health Sciences/McMaster University
- Studie directeur: Bradley Yoder, MD, University of Utah
- Studie directeur: Peter H Dijk, MD, PhD, University Medical Centrum Groningen
Publicaties en nuttige links
Algemene publicaties
- Kirpalani H, Millar D, Lemyre B, Yoder BA, Chiu A, Roberts RS; NIPPV Study Group. A trial comparing noninvasive ventilation strategies in preterm infants. N Engl J Med. 2013 Aug 15;369(7):611-20. doi: 10.1056/NEJMoa1214533.
- Bamat NA, Guevara JP, Bryan M, Roberts RS, Yoder BA, Lemyre B, Chiu A, Millar D, Kirpalani H. Variation in Positive End-Expiratory Pressure Levels for Mechanically Ventilated Extremely Low Birth Weight Infants. J Pediatr. 2018 Mar;194:28-33.e5. doi: 10.1016/j.jpeds.2017.10.065. Epub 2017 Dec 22.
- Millar D, Lemyre B, Kirpalani H, Chiu A, Yoder BA, Roberts RS. A comparison of bilevel and ventilator-delivered non-invasive respiratory support. Arch Dis Child Fetal Neonatal Ed. 2016 Jan;101(1):F21-5. doi: 10.1136/archdischild-2014-308123. Epub 2015 Jul 10.
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Schatting)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
- Ziekten van de luchtwegen
- Ademhalingsstoornissen
- Longziekten
- Baby, pasgeborene, ziekten
- Zwangerschap Complicaties
- Verloskundige arbeidscomplicaties
- Verloskundige arbeid, voortijdig
- Longletsel
- Zuigelingen, prematuren, ziekten
- Door beademing veroorzaakt longletsel
- Ademhalingsinsufficiëntie
- Voortijdige geboorte
- Bronchopulmonale dysplasie
Andere studie-ID-nummers
- NTG-2007-NIPPV
- CIHR MCT-80246
- ISRCTN15233270
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .